Australia Increases The Pfizer Inc (NYSE:PFE) Vaccine Order As Astra’s Roll Out Grinds To A Halt
Australia has decided to increase its Pfizer Inc (NYSE:PFE) COVID-19 vaccine by almost double. It was on Friday that Prime
Read more
NYSE:PFE
Biden Administration Expecting 200 million Vaccine Doses From Moderna (NASDAQ:MRNA) and Pfizer Inc. (NYSE:PFE)
The US president Joe Biden has indicated that they have finalized the deal with Moderna (NASDAQ:MRNA) and Pfizer Inc. (NYSE:PFE)
Read more
Pfizer Inc. (NYSE:PFE) In Discussions To Supply South Africa COVID-19 vaccine At $10 Per Dose
Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) have announced that they will offer South Africa discounted COVID-19 vaccine at $10
Read more
Myovant Sciences (NYSE:MYOV) Enters Collaboration With Pfizer Inc. (NYSE:PFE) for Development and Commercialization of ORGOVYX™
Myovant Sciences (NYSE:MYOV) has announced a collaboration with Pfizer Inc. (NYSE:PFE) for the development and commercialization of relugolix (ORGOVYX) in
Read more
Pfizer Inc. (NYSE:PFE) In Discussions With Federal Government Of Brazil for Supply Of Its COVID-19 Vaccine
Pfizer Inc. (NYSE:PFE) has engaged the Brazilian Government to supply its investigational COVID-19 vaccine to the country in Q1 2021.
Read more
Pfizer Inc. (NYSE:PFE) And BioNTech SE (NASDAQ:BNTX) Commence COVID-19 Vaccine Trial In Japan
Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) has announced the commencement of combined Phase I & II clinical study of
Read more
Pfizer Inc. (NYSE:PFE) Expands Its COVID-19 Trial To Include Children Of 12 Years
Pfizer Inc. (NYSE:PFE) has announced that it will begin testing its investigational COVID-19 vaccine candidate in children from 12 years.
Read more
Ro Extends Its Partnership With Pfizer Inc. (NYSE:PFE) To Provide Affordable Generic Medications To Patient Populations With Hypertension And Cholesterol
Ro extended its alliance with Pfizer Inc. (NYSE:PFE) to serve patients suffering from hypertension and cholesterol in the US. It
Read more
Pfizer Inc. (NYSE:PFE) Upbeat That Its COVID-19 Vaccine Will Show Effectiveness By End Of October
Pfizer Inc. (NYSE:PFE) is upbeat that its COVID-19 vaccine candidate will demonstrate early evidence of effectiveness in clinical trials that
Read moreUS Agrees To Pay Pfizer Inc. (NYSE:PFE) $2bn To Fast Track Hunt For COVID-19 Vaccine
Pfizer Inc. (NYSE:PFE) reached an agreement with the US government to supply 100 million doses of a vaccine the company
Read more